Rankings
▼
Calendar
BMRN FY 2017 Earnings — BioMarin Pharmaceutical Inc. Revenue & Financial Results | Market Cap Arena
BMRN
BioMarin Pharmaceutical Inc.
$12B
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.3B
+17.6% YoY
Gross Profit
$1.1B
81.6% margin
Operating Income
-$15M
-1.1% margin
Net Income
-$117M
-8.9% margin
EPS (Diluted)
$-0.67
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$208M
Stock-Based Comp.
$140M
Balance Sheet
Total Assets
$4.6B
Total Liabilities
$1.8B
Stockholders' Equity
$2.8B
Cash & Equivalents
$598M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.3B
$1.1B
+17.6%
Gross Profit
$1.1B
$907M
+18.1%
Operating Income
-$15M
-$803M
+98.2%
Net Income
-$117M
-$630M
+81.4%
← Q4 2016
All Quarters
Q1 2017 →